Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01893788
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Nagoya University
- Registry
-
NCT01893788
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Japan
- Registry status
- Unknown status
Technical summary
Registry record NCT01893788. Randomized; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
- Acronym
- EARTH
- Condition
- Hypertensive Left Ventricular Hypertrophy
- Intervention (Drug)
- Aliskiren
- Intervention (Drug)
- Eplerenone
- Lead sponsor
- Nagoya University
Record details
- Record id
cardio:ct-nct01893788- Content hash
eaa952f60c1f90b3424233ae623dd4634588b124a562da93f7e03e584bf991a5